News and events

Neuroscience Trials Office
Birmingham Clinical Trials Unit
Public Health Building
University of Birmingham
Birmingham
B15 2TT

BCTU is closed on the 25th and 26th of August. We will unavailable by phone on these dates but we will respond to emails on our return.

We have invited a number of people with Parkinson's and their carers to join our Patient and Public Involvement Group. The purpose of this group is to improve our research by ensuring we are asking the right questions and are communicating with trial participants & the broader community most effectively. Over the past few weeks, the group has already kindly given us a helping hand on the grant application and result dissemination.

The trials team would like to thank those who have joined the group and kindly spent time on our research, helping to bring our research closer to patients and the public.

The PD COMM Pilot study aims to evaluate the feasibility of a full scale trial on the effectiveness and cost effectiveness of two types of speech and language therapy for people with Parkinson's who have self reported problems with voice or speech. This paper described fully the design of the study. For further details please visit our Publication page.

The trials team had presented 3 posters at the 18th International Congress of Parkinson's disease and Movement Disorders in Stockholm, June 2014. These include:

• PD COMM Pilot baseline data
• PD REHAB Trial results, which was selected for the Guided Poster Tours
• Characteristics of PD patients admitted to a tertiary hospital